Butterfly Network, Inc. (NYSE:BFLY – Get Free Report) EVP John Doherty sold 57,136 shares of the stock in a transaction that occurred on Monday, July 20th. The shares were sold at an average price of $6.56, for a total transaction of $374,812.16. Following the completion of the sale, the executive vice president owned 1,397,276 shares in the company, valued at $9,166,130.56. This represents a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Butterfly Network Stock Up 0.2%
NYSE BFLY traded up $0.01 during trading on Tuesday, reaching $7.08. 1,379,999 shares of the stock traded hands, compared to its average volume of 6,676,768. Butterfly Network, Inc. has a fifty-two week low of $1.32 and a fifty-two week high of $9.69. The firm has a market cap of $1.80 billion, a price-to-earnings ratio of -23.74 and a beta of 2.05. The stock’s 50-day moving average price is $6.42 and its 200 day moving average price is $4.92.
Butterfly Network (NYSE:BFLY – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01. Butterfly Network had a negative net margin of 73.63% and a negative return on equity of 34.41%. The company had revenue of $26.53 million for the quarter, compared to analysts’ expectations of $26.08 million. Analysts anticipate that Butterfly Network, Inc. will post -0.18 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Get Our Latest Report on Butterfly Network
Key Stories Impacting Butterfly Network
Here are the key news stories impacting Butterfly Network this week:
- Positive Sentiment: Analysts are watching for continued momentum in Butterfly’s iQ3 handheld ultrasound system, Compass AI software adoption and growth in its Embedded business. Revenue is expected to increase approximately 21.5% in the second quarter, creating a potential catalyst if results and guidance meet or exceed expectations. Can AI Momentum and Embedded Growth Lift BFLY’s Q2 Results?
- Neutral Sentiment: Rothberg’s sales were conducted through pre-arranged 10b5-1 trading plans and were reportedly tied to estate planning, which reduces the likelihood that they reflect a negative view of Butterfly’s business. The company’s stock has also risen sharply over the past year, providing a possible explanation for the timing. Butterfly Network Founder Rothberg Sells Another 660,000 Shares. Should Investors Worry?
- Negative Sentiment: Rothberg sold approximately 3.79 million shares from July 17 through July 22 for about $25.0 million in total. The transactions reduced his direct ownership by roughly 95.7% from the July 17 filing and by 60.3% in the subsequent sale, leaving investors with a significant insider-selling signal and additional potential supply of shares.
Institutional Trading of Butterfly Network
Institutional investors have recently added to or reduced their stakes in the company. KBC Group NV acquired a new position in Butterfly Network in the 1st quarter valued at $25,000. Ameriprise Financial Inc. bought a new position in Butterfly Network in the third quarter valued at approximately $25,000. BNP Paribas Financial Markets raised its position in Butterfly Network by 707.2% during the second quarter. BNP Paribas Financial Markets now owns 16,258 shares of the company’s stock valued at $33,000 after purchasing an additional 14,244 shares in the last quarter. ExodusPoint Capital Management LP acquired a new stake in shares of Butterfly Network in the 4th quarter valued at $38,000. Finally, Sfmg LLC bought a new position in Butterfly Network in the fourth quarter valued at about $39,000. 37.85% of the stock is currently owned by institutional investors.
Butterfly Network Company Profile
Butterfly Network, Inc is a medical technology company focused on democratizing access to diagnostic imaging through its proprietary ultrasound-on-chip platform. The company’s flagship device, the Butterfly iQ, leverages semiconductor technology to deliver whole-body ultrasound imaging in a handheld form factor. This portable system connects to a compatible smart device, enabling point-of-care scanning across a variety of clinical settings.
Beyond its hardware offering, Butterfly Network provides a cloud-based software suite that supports image storage, analysis and remote collaboration.
Featured Stories
- Five stocks we like better than Butterfly Network
- Is the Market Mispricing ServiceNow’s AI Future?
- Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in Focus
- Amkor Sells Off After Earnings—Why Weak Guidance Isn’t the Real Story
- 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?
Receive News & Ratings for Butterfly Network Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Butterfly Network and related companies with MarketBeat.com's FREE daily email newsletter.
